Comprehensive analysis of Quant Manufacturing Fund - Direct (IDCW) (44254) providing detailed insights into fund performance, portfolio holdings, risk metrics, expense ratios, and investment recommendations.
Quant Money Managers Limited
The primary objective of the scheme is to generate long term capital appreciation by investing in equity and equity related instruments of companies that follow the manufacturing theme. However, there is no assurance or guarantee that the investment objective of the Scheme will be achieved. The Scheme does not assure or guarantee any returns.
A comprehensive at-a-glance view of key mutual fund health indicatorsHover or click any card to view detailed metrics
Weak Returns
High Risk
Low Expense Ratio
Diversified
Established Team
Below Average
Showing 1Y NAV history
Performance across different time periods
Fund shows concerning indicators. Exercise caution before investing.
Consider waiting for better market conditions or explore alternatives.
Fund shows concerning indicators. Exercise caution before investing.
Consider waiting for better market conditions or explore alternatives.
Historical performance consistency
Market exposure level
Fund management costs
Outperformance vs benchmark
Fund manager experience
Risk-adjusted returns
Assets under management
Recent performance momentum
This fund has underperformed its benchmark by 13.28% over the 3Y period.
See how your money can grow and compare with popular investment options
Disclaimer: Returns are illustrative and based on assumed rates. Mutual fund investments are subject to market risk. Please read scheme documents carefully.
| Company | Industry | % Assets |
|---|---|---|
| TREPS | Debt Others | 13.22% |
| Aurobindo Pharma Ltd | Pharmaceuticals | 8.59% |
| Samvardhana Motherson International Ltd | Auto Ancillaries | 8.10% |
| Zydus Wellness Ltd | FMCG | 6.17% |
| Tata Power Company Ltd | Power Generation And Supply | 6.09% |
| TBILL-91D | T Bills | 5.69% |
| Anthem Bioscienc | - | 5.14% |
| Himadri Speciality Chemical Ltd | Chemicals | 4.76% |
| Gujarat Themis Biosyn Ltd | Pharmaceuticals | 4.74% |
| Ador Welding Ltd | Capital Goods-Non Electrical Equipment | 4.61% |
Compare against Sectoral / Thematic category average
This comparison shows how the fund performs relative to the Sectoral / Thematic category average. Positive values indicate outperformance, while negative values show underperformance.
Compare with similar funds in Sectoral / Thematic category
| Fund Name | NAV | 3M | 6M | 1Y |
|---|---|---|---|---|
| Aditya Birla SL MNC Fund - Direct (G) | ₹1540.61 | 4.17% | 20.90% | -2.29% |
| Aditya Birla SL MNC Fund - (G) | ₹1383.22 | 3.98% | 20.48% | -2.95% |
| Nippon India Banking&Financial Services-Dir(G) | ₹662.94 | -2.23% | 13.57% | 4.61% |
| Nippon India Banking&Financial Services-Dir(Bonus) | ₹662.94 | -2.23% | 13.57% | 4.61% |
| Nippon India Banking&Financial Services (G) | ₹606.00 | -2.44% | 13.09% | 3.74% |
| Nippon India Banking&Financial Services (Bonus) | ₹606.00 | -2.44% | 13.09% | 3.74% |
| Nippon India Pharma Fund - Direct (G) | ₹574.98 | 2.59% | 13.30% | 0.45% |
| Nippon India Pharma Fund - Direct (Bonus) | ₹574.98 | 2.59% | 13.30% | 0.45% |
| Franklin India Technology Fund - Direct (G) | ₹565.29 | 3.31% | 7.85% | -5.66% |
| ICICI Pru FMCG Fund - Direct (G) | ₹542.41 | 3.11% | 13.18% | -7.36% |
A seasoned investment professional with over 2 years of experience in equity research and fund management. Known for consistent performance and a disciplined investment approach focused on quality growth stocks.